| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |